132 related articles for article (PubMed ID: 9039203)
1. Cutaneous involvement in prelymphomatous angioimmunoblastic lymphadenopathy.
Schmuth M; Ramaker J; Trautmann C; Hummel M; Schmitt-Gräff A; Stein H; Goerdt S
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 2):290-5. PubMed ID: 9039203
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression.
Brown HA; Macon WR; Kurtin PJ; Gibson LE
J Cutan Pathol; 2001 Sep; 28(8):432-8. PubMed ID: 11493382
[TBL] [Abstract][Full Text] [Related]
3. Lymph node pathology in patients with a clinical diagnosis of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD): an analysis of 37 cases.
Upara S; Ruchutrakool T; Sukpanichnant S
Asian Pac J Allergy Immunol; 1997 Mar; 15(1):15-20. PubMed ID: 9251843
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia: a clinical, immunohistological, and molecular analysis.
Martel P; Laroche L; Courville P; Larroche C; Wechsler J; Lenormand B; Delfau MH; Bodemer C; Bagot M; Joly P
Arch Dermatol; 2000 Jul; 136(7):881-6. PubMed ID: 10890990
[TBL] [Abstract][Full Text] [Related]
5. Cell dynamics and expression of tumor necrosis factor (TNF)-alpha, interleukin-6, and TNF receptors in angioimmunoblastic lymphadenopathy-type T cell lymphoma.
Yamaguchi S; Kitagawa M; Inoue M; Tomizawa N; Kamiyama R; Hirokawa K
Exp Mol Pathol; 2000 Apr; 68(2):85-94. PubMed ID: 10716912
[TBL] [Abstract][Full Text] [Related]
6. Angioimmunoblastic lymphadenopathy with dysproteinemia following doxycycline administration.
Batinac T; Zamolo G; Jonjić N; Gruber F; Nacinović A; Seili-Bekafigo I; Coklo M
Tumori; 2003; 89(1):91-5. PubMed ID: 12729371
[TBL] [Abstract][Full Text] [Related]
7. A case of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) together with total atelectasis of a lung caused by lymphadenopathy and pleural effusion.
Yoshii C; Kurita Y; Noda Y; Kido M
J UOEH; 2000 Mar; 22(1):7-12. PubMed ID: 10736820
[TBL] [Abstract][Full Text] [Related]
8. Clonal T cell population in angioimmunoblastic lymphadenopathy and related lesions.
Suzuki H; Namikawa R; Ueda R; Obata Y; Suchi T; Kikuchi M; Ota K; Takahashi T
Jpn J Cancer Res; 1987 Jul; 78(7):712-20. PubMed ID: 3114197
[TBL] [Abstract][Full Text] [Related]
9. Angioimmunoblastic lymphadenopathy with dysproteinemia: thoracic involvement.
Singh MK; Solanki RN; Shah NJ; Tanna D; Patel DR; Desai IM
Indian J Chest Dis Allied Sci; 2004; 46(2):125-8. PubMed ID: 15072329
[TBL] [Abstract][Full Text] [Related]
10. [Angioblastic lymphadenopathy--its course and prognosis].
Mihaljević B; Jancić-Nedeljkov R; Janković S; Milivojević G; Cemerikić-Martinović V; Jovanović V; Colović M; Petrović M
Srp Arh Celok Lek; 1999; 127(11-12):376-82. PubMed ID: 10686819
[TBL] [Abstract][Full Text] [Related]
11. Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.
Weiss LM; Strickler JG; Dorfman RF; Horning SJ; Warnke RA; Sklar J
Am J Pathol; 1986 Mar; 122(3):392-7. PubMed ID: 3082212
[TBL] [Abstract][Full Text] [Related]
12. [Angioimmunoblastic lymphadenopathy and angioimmunoblastic T-cell lymphoma].
Li T; Gao D; Zhang B
Zhonghua Bing Li Xue Za Zhi; 1996 Apr; 25(2):99-101. PubMed ID: 9206215
[TBL] [Abstract][Full Text] [Related]
13. Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma.
Lipford EH; Smith HR; Pittaluga S; Jaffe ES; Steinberg AD; Cossman J
J Clin Invest; 1987 Feb; 79(2):637-42. PubMed ID: 3805286
[TBL] [Abstract][Full Text] [Related]
14. [Angioimmunoblastic lymphadenopathy accompanied by Duhring disease-like lesions ].
Zumdick M; Megahed M; Borchard F; Wohde D; Goerz G
Hautarzt; 1994 Aug; 45(8):562-5. PubMed ID: 7960758
[TBL] [Abstract][Full Text] [Related]
15. Angioimmunoblastic lymphadenopathy with dysproteinemia: emphasis on pathogenesis and treatment.
Sallah S; Gagnon GA
Acta Haematol; 1998; 99(2):57-64. PubMed ID: 9554450
[TBL] [Abstract][Full Text] [Related]
16. Angioimmunoblastic lymphadenopathy type of T-cell lymphoma and angioimmunoblastic lymphadenopathy: a clinicopathological and molecular biological study of 13 Chinese patients using polymerase chain reaction and paraffin-embedded tissues.
Lorenzen J; Li G; Zhao-Höhn M; Wintzer C; Fischer R; Hansmann ML
Virchows Arch; 1994; 424(6):593-600. PubMed ID: 8055152
[TBL] [Abstract][Full Text] [Related]
17. [Seropositive polyarthritis as a presentation form of angioimmunoblastic lymphadenopathy].
Bistué R; Scognamillo C; Lovato G; Parra G; Maddio J; Roselli G
Medicina (B Aires); 1993; 53(5):435-8. PubMed ID: 8201932
[TBL] [Abstract][Full Text] [Related]
18. Angioimmunoblastic lymphadenopathy.
Su WP
Dermatol Clin; 1985 Oct; 3(4):759-68. PubMed ID: 3916179
[TBL] [Abstract][Full Text] [Related]
19. Development of Epstein-Barr virus-associated B cell lymphoma after intensive treatment of patients with angioimmunoblastic lymphadenopathy with dysproteinemia.
Matsue K; Itoh M; Tsukuda K; Kokubo T; Hirose Y
Int J Hematol; 1998 Apr; 67(3):319-29. PubMed ID: 9650454
[TBL] [Abstract][Full Text] [Related]
20. Frequent detection of human herpesvirus-6 sequences by polymerase chain reaction in paraffin-embedded lymph nodes from patients with angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.
Luppi M; Marasca R; Barozzi P; Artusi T; Torelli G
Leuk Res; 1993 Nov; 17(11):1003-11. PubMed ID: 8231227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]